Leah Brownlee is a member of our Corporate Practice Group, where she advises corporate and securities law matters within the life sciences industry and more broadly, in the tech sector, including venture capital and strategic financing, public and private capital markets transactions, securities law compliance, stock exchange listing requirements, strategic intellectual property advice and corporate governance, and international business transactions. She also has expertise in counseling public and private companies in connection with other corporate transactions, including mergers, acquisitions, dispositions and joint ventures, manufacturing, distribution and research agreements, and on general business matters.
Leah previously worked for the firm, and another global law firm, as an associate in the Corporate Practice Group, where she counseled public and private companies in connection with corporate transactions, including mergers, acquisitions, dispositions and joint ventures, and on general business and securities law matters.
Prior to returning to our firm in 2016, Leah served in-house for life sciences companies in executive and board level assignments, providing her with a unique perspective on the challenges and opportunities that growing companies in this field face across this global industry.
She is a Vice Chair of the American Health Lawyers Association's Life Science Practice Group and a Vice Chair of the American Bar Association, Biotechnology Committee. She is also a member of the Food Drug Law Institute and is active in BioOhio.
